PTA-DD
Medigene AG: Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
Planegg (pta016/08.12.2017/20:10) - Announcement
1 | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Dr. Thomas Taapken |
2 | Reason for the notification | |
a) | Position/status | Executive Board Member |
b) | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Medigene AG |
b) | LEI | 391200I33JD2DKZGDX06 |
4 | Details of the transaction(s) | |
a) | Description of the financial instrument, type of instrument | Share |
Identification code | ISIN: DE000A1X3W00 | |
b) | Nature of the transaction | Acceptance of the granting of 20,000 stock options of Medigene AG as part of the stock option program for management board members of Medigene AG |
c) | Price(s) | Volume(s) |
0 | 0 | |
d) | Aggregated price | Aggregated volume |
e) | Date of the transaction | 08.12.2017 UTC+1 |
f) | Place of the transaction | OTC |
(end)
emitter: Medigene AG
address: Lochhamer Straße 11, 82152 Planegg
country: Germany
contact person: Medigene PR/IR
phone: +49 89 2000 33 3301
e-mail: investor@medigene.com
website: www.medigene.de
ISIN(s): DE000A1X3W00 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin,
Tradegate
Lesen Sie auch
[ source: http://www.pressetext.com/news/20171208016 ]
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
1 im Artikel enthaltener WertIm Artikel enthaltene Werte